ND PHARMA S.R.L: public contracts won without a rival in Romania

Updated 17 October 2026 · 2023-12-15 to 2026-09-30 · all of Romania · record in the register

ND PHARMA S.R.L: public contracts won without a rival in Romania: 16 uncontested awards; 1% of its awards; 0 without a competition; 16 single bid.

Assay record ASY-RO-13GSF6U0LG · Cite as: Assay Systems, “ND PHARMA S.R.L: public contracts won without a rival in Romania”, https://assay-systems.com/register/ro/uncontested/s/nd-pharma-s-r-l/

1
16uncontested awards
1%of its awards
0without a competition
16single bid

ND PHARMA S.R.L won 16 of its 2,080 public contract awards in Romania without a rival from 2023-12-15 to 2026-09-30: 0 without a competition and 16 after a competition that drew a single bid. 7 buyers awarded it without a rival, the largest Penitenciar Spital Bucuresti Jilava with 5.

An award is uncontested when the buyer had no rival offer to weigh: it was made without a competition (direct award, negotiated procedure without a call for tenders, sole-source or advance-notice contract), or a competition was held and only one bid arrived. Every count below is built award by award from the official notices. Awards to individuals are not included.

Buyers that awarded it without a rival

Penitenciar Spital Bucuresti Jilava5uncontested68awards7%of these awards

Penitenciar Spital Bucuresti Jilava gave ND PHARMA S.R.L 68 awards: 0 without a competition, 5 after a competition with a single bid. First 2024-01-04, latest 2026-09-03.

SPITALUL CLINIC JUDETEAN MURES3uncontested164awards2%of these awards

SPITALUL CLINIC JUDETEAN MURES gave ND PHARMA S.R.L 164 awards: 0 without a competition, 3 after a competition with a single bid. First 2024-01-12, latest 2026-09-16.

Spitalul Judetan de Urgenta "Mavromati" Botosani2uncontested169awards1%of these awards

Spitalul Judetan de Urgenta "Mavromati" Botosani gave ND PHARMA S.R.L 169 awards: 0 without a competition, 2 after a competition with a single bid. First 2023-12-15, latest 2026-09-02.

Institutul Național de Boli Infecțioase "Prof. Dr. Matei Balș"2uncontested78awards3%of these awards

Institutul Național de Boli Infecțioase "Prof. Dr. Matei Balș" gave ND PHARMA S.R.L 78 awards: 0 without a competition, 2 after a competition with a single bid. First 2024-06-13, latest 2026-07-16.

Spitalul de Recuperare "Sf.Gheorghe" Botosani2uncontested35awards6%of these awards

Spitalul de Recuperare "Sf.Gheorghe" Botosani gave ND PHARMA S.R.L 35 awards: 0 without a competition, 2 after a competition with a single bid. First 2024-01-11, latest 2026-09-30.

SPITALUL DE BOLI PSIHICE CRONICE BORSA1uncontested27awards4%of these awards

SPITALUL DE BOLI PSIHICE CRONICE BORSA gave ND PHARMA S.R.L 27 awards: 0 without a competition, 1 after a competition with a single bid. First 2024-02-01, latest 2026-08-17.

MINISTERUL APARARII - UNITATEA MILITARA 02497 PITESTI1uncontested24awards4%of these awards

MINISTERUL APARARII - UNITATEA MILITARA 02497 PITESTI gave ND PHARMA S.R.L 24 awards: 0 without a competition, 1 after a competition with a single bid. First 2024-03-06, latest 2026-05-27.

Latest awards without a rival

DateBuyerHowStated reason
2024-10-16SPITALUL CLINIC JUDETEAN MURES
623859-2024
Single bid
open
—
2024-10-08Institutul Național de Boli Infecțioase "Prof. Dr. Matei Balș"
604523-2024
Single bid
open
—
2024-08-27Penitenciar Spital Bucuresti Jilava
513381-2024
Single bid
open
—
2024-08-23SPITALUL DE BOLI PSIHICE CRONICE BORSA
506509-2024
Single bid
open
—
2024-08-08Spitalul Judetan de Urgenta "Mavromati" Botosani
477395-2024
Single bid
open
—
2024-06-27Institutul Național de Boli Infecțioase "Prof. Dr. Matei Balș"
382705-2024
Single bid
open
—

Every uncontested award in Romania · All countries · ND PHARMA S.R.L in the register

Source: Tenders Electronic Daily (TED), Publications Office of the European Union, contract award notices. Awards are matched to their buyer and supplier as published. Values in these notices often state a framework ceiling rather than a contract amount, so awards are counted, not summed. Updated 17 October 2026.